Dipeptidyl peptidase‐4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin‐secreting capacity, a higher body mass index and insulin resistance

@inproceedings{Kozawa2013DipeptidylPI,
  title={Dipeptidyl peptidase‐4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin‐secreting capacity, a higher body mass index and insulin resistance},
  author={Junji Kozawa and Tetsuhiro Kitamura and Hitoshi Nishizawa and Tetsuyuki Yasuda and Norikazu Maeda and Michio Otsuki and Kohei Okita and Hiromi Iwahashi and Hideaki Kaneto and Tohru Funahashi and Akihisa Imagawa and Iichiro Shimomura},
  booktitle={Journal of diabetes investigation},
  year={2013}
}
AIMS/INTRODUCTION Recently, dipeptidyl peptidase-4 (DPP-4) inhibitors have become available in Japan. It has not yet been clarified what clinical parameters could discriminate DPP-4 inhibitor-effective patients from DPP-4 inhibitor-ineffective patients. MATERIALS AND METHODS We reviewed 33 consecutive patients with type 2 diabetes admitted to Osaka University Hospital for glycemic control. All of the patients were treated with medical nutrition therapy plus insulin therapy to improve fasting… CONTINUE READING
Highly Cited
This paper has 75 citations. REVIEW CITATIONS

Citations

Publications citing this paper.

76 Citations

05010020142015201620172018
Citations per Year
Semantic Scholar estimates that this publication has 76 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Similar Papers

Loading similar papers…